PureHealth Reports AED 505 Million Net Profit and AED 1.1 Billion EBITDA for Q1 2025, Signaling Strong Start to the Year
PureHealth Holding PJSC (ADX: PUREHEALTH), the largest integrated healthcare platform in the Middle East, has announced robust financial results for the first quarter ended March 31, 2025. The Group reported a net profit of AED 505 million, marking a 3% year-on-year (YoY) increase, alongside EBITDA of AED 1.1 billion, up 5% YoY. Total revenue for the quarter reached AED 6.6 billion, an 8% YoY growth driven by the strong performance of all core business segments.
These results underscore the Group’s continued momentum and its commitment to transforming the healthcare landscape in the UAE and abroad through technology-driven innovation, global expansion, and operational efficiency.
Sustained Growth Across Core Segments
PureHealth’s revenue growth in Q1 2025 was broad-based, reflecting healthy performance across its diversified portfolio of healthcare assets, including hospitals, diagnostics, insurance, pharmacies, and health tech. The 8% YoY increase in total revenue to AED 6.6 billion was attributed to higher patient volumes, improved throughput across its hospital network, and rising demand for medical services in both domestic and international markets.
The Group’s hospital segment delivered particularly strong results, bolstered by strategic investments in capacity expansion, digital health infrastructure, and the continued rollout of advanced medical technologies. International patient inflows also contributed significantly to revenue, driven by PureHealth’s growing reputation as a destination for specialized care and complex medical procedures.
Meanwhile, PureHealth’s insurance arm demonstrated continued strength with high policy renewal rates and geographic expansion into new markets. The division maintained solid underwriting performance while scaling its digital health insurance solutions aimed at improving patient access and optimizing cost-efficiency across the healthcare continuum.
Profitability Anchored in Operational Excellence
EBITDA increased 5% YoY to AED 1.1 billion, driven by cost optimization, enhanced procurement processes, and operating leverage from growing volumes. The Group continued to implement digital transformation initiatives and process automation across its entities, leading to higher efficiencies and reduced administrative overhead.
Net profit for the quarter rose to AED 505 million, up 3% from the same period last year. This steady profitability was underpinned by disciplined capital allocation, effective integration of acquired assets, and strong synergy realization from the Group’s expanding ecosystem.
The Group’s focus on long-term sustainable growth and delivering shareholder value remained evident in its financial performance and strategic decisions.
Leadership Commentary on Strategic Direction
Commenting on the quarterly performance, H.E. Kamal Al Maazmi, Chairman of PureHealth, emphasized the strength of the Group’s integrated healthcare model and its long-term vision.
“PureHealth’s strong Q1 2025 results underscore the strength of our integrated healthcare model and the resilience of our long-term strategy. We are redefining healthcare delivery by combining operational excellence with cutting-edge innovation to raise the standard of care across the region and beyond,” said Al Maazmi.
He added, “As we continue to expand our global presence and invest in future-ready medical capabilities, our focus remains clear—delivering superior patient care, creating sustainable value for our shareholders, and making a meaningful, long-term impact on the health and well-being of the communities we serve.”
Shaista Asif, Group Chief Executive Officer at PureHealth, highlighted the contributions of the Group’s diverse assets and forward-looking approach.
“PureHealth’s first quarter results reflect the solid growth witnessed across all core segments. The Group’s results for the period came on the back of strong patient volume increases across our hospital network, both locally and internationally, and continued momentum in our insurance division with high renewal rates and expansion into new markets,” Asif stated.
She further noted, “Our strong operational execution, transformations of the assets, and the synergies between the entities are delivering tangible results, and strengthening the foundation for future growth. As we look ahead, PureHealth is well-positioned to continue expanding our reach, deepening our platform capabilities, and advancing specialised care to meet the evolving needs of the healthcare sector both in the UAE and internationally.”
Strategic Investments and Global Expansion
In recent quarters, PureHealth has accelerated its strategic investment agenda, reinforcing its status as a global healthcare leader. The Group’s acquisition strategy continues to focus on synergistic targets that complement its existing capabilities while expanding its international footprint.
Earlier this year, PureHealth completed the integration of several key international and regional healthcare assets, enhancing the Group’s service portfolio and geographic reach. These acquisitions are expected to contribute positively to future earnings and further strengthen PureHealth’s global position.
In addition, PureHealth is investing significantly in digital health technologies, artificial intelligence, and data analytics to drive innovation and patient outcomes. The Group’s technology arm is spearheading the development of smart hospitals, digital diagnostics, and personalized care platforms—critical areas of focus that will define the future of healthcare delivery.
Commitment to Patient-Centric Innovation
PureHealth’s strategy is rooted in a patient-centric approach that aims to deliver world-class care while improving system-wide outcomes. This is being achieved through investments in clinical excellence, workforce training, and data-driven healthcare solutions.
The Group continues to make significant progress in areas such as precision medicine, chronic disease management, and value-based care—ensuring that healthcare is not only accessible but also tailored to the individual needs of patients. Key initiatives during the quarter included the rollout of AI-powered diagnostic tools, telehealth service expansion, and enhancements to patient engagement platforms.
PureHealth remains confident in its ability to sustain growth and deliver value, supported by a resilient operating model, expanding global partnerships, and a commitment to healthcare innovation.
Management reaffirmed its outlook for the full year 2025, expecting continued revenue growth and margin improvement across all key business lines. Strategic priorities for the remainder of the year include further international expansion, accelerating digital transformation, and enhancing patient pathways through integrated care models.
With a strong balance sheet, proven execution capabilities, and a clear strategic roadmap, PureHealth is well-positioned to lead the transformation of the healthcare ecosystem in the UAE and beyond.
PureHealth Holding PJSC is the Middle East’s largest integrated healthcare platform, committed to advancing the science of longevity and delivering world-class healthcare solutions. Headquartered in Abu Dhabi, the Group operates an extensive portfolio of hospitals, clinics, diagnostic centers, insurance services, pharmacies, and health technology solutions. With a mission to deliver health for humanity, PureHealth is shaping the future of healthcare through innovation, integration, and a relentless focus on excellence.
